AI assistant
Sending…
Anika Therapeutics, Inc. — Director's Dealing 2020
Sep 8, 2020
33997_dirs_2020-09-08_dd8395d2-e442-43ee-8632-9d22b9621153.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Anika Therapeutics, Inc. (ANIK)
CIK: 0000898437
Period of Report: 2020-09-03
Reporting Person: HENNEMAN JOHN B III (Director)
More from Anika Therapeutics, Inc.
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18